Holen Sie sich die Stockscreener-App
0.9737
4.82%
0.0448
Schlusskurs vom Vortag:
$0.9289
Offen:
$0.95
24-Stunden-Volumen:
158.15K
Relative Volume:
0.06
Marktkapitalisierung:
$14.49M
Einnahmen:
$3,000
Nettoeinkommen (Verlust:
$-7.78M
KGV:
-0.9411
EPS:
-1.0346
Netto-Cashflow:
$-7.49M
1W Leistung:
-0.47%
1M Leistung:
+21.41%
6M Leistung:
-14.59%
1J Leistung:
-48.48%
1-Tages-Spanne:
$0.9103
$0.98
1-Wochen-Bereich:
$0.8521
$0.987
52-Wochen-Spanne:
$0.75
$2.29
Biocardia Inc Stock (BCDA) Company Profile
Firmenname
Biocardia Inc
Sektor
Branche
Telefon
650-226-0123
Adresse
320 SOQUEL WAY, SUNNYVALE, CA
Compare BCDA vs MOBBW, PSNYW, GOODO, SHMD, DWLD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 0.41 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
1.86 | 2.83B | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.89 | 388.34M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
20.88 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
5.45 | 348.74M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
48.03 | 0 | 0 | 0 | 0 | 0.00 |
Biocardia Inc Stock (BCDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-04-16 | Herabstufung | Dawson James | Buy → Neutral |
Biocardia Inc Aktie (BCDA) Neueste Nachrichten
BioCardia CEO Peter Altman buys $1,748 in company stock - Investing.com
BioCardia CEO Peter Altman buys $1,748 in company stock By Investing.com - Investing.com India
BioCardia (BCDA) CEO Peter Altman purchases 1,900 shares at $0.92 average price - Stock Titan
BioCardia (BCDA) Advances Regulatory Pathway, Faces High Price-t - GuruFocus
BioCardia Inc (BCDA) (Q2 2026) Earnings Call Highlights: Regulatory Wins in Japan and US ... - Yahoo! Finance Canada
BioCardia Inc (BCDA) (Q2 2026) Earnings Call Highlights: Regulat - GuruFocus
BioCardia, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
BioCardia Q2 loss narrows 67.5% YoY; regulatory milestones advance - scanx.trade
BCDA: Regulatory milestones and strong cash position support major market entry for cardiac therapies - TradingView
Earnings call transcript: BioCardia posts q2 2026 loss beat, shares rise after hours - Investing.com
Is BioCardia Inc (BCDA) Facing Financial Challenges After Q2 Ear - GuruFocus
BioCardia reports Q2 2026 net loss narrows to $1.6M; cash $4.1M with runway into 2027 - TradingView
BioCardia Reports Q2 2026 Net Loss of $1.6 Million - quiverquant.com
Q2 2026 BioCardia Inc Earnings Call Transcript - GuruFocus
BCDA: Regulatory progress, clinical advances, and improved financials position for late 2026 submissions - TradingView
BioCardia, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BioCardia Reports Second Quarter 2026 Business Highlights and Financial Results - The Manila Times
BRIEF-BioCardia, Inc. Q2 Net Income USD -1.613 Million - TradingView
BioCardia (BCDA.US) will release its earnings report before market open on August 12. - Moomoo
BioCardia Inc (BCDA) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
BioCardia, Inc. Revenue Breakdown – NASDAQ:BCDA - TradingView
BioCardia Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
BioCardia Inc (BCDA) Stock News Today - tradingkey.com
Insiders In BioCardia Still Down 21% On US$1.08m Investment - simplywall.st
BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026 - The Manila Times
BioCardia to Report Second Quarter 2026 Financial Results and Provide Corporate Update on August 12 Conference Call - quiverquant.com
BioCardia Sets Live Webcast for Q2 Results on Aug. 12 - Stock Titan
BCDA Q2'26 Earnings: revenue estimate is 0 USD - TradingView
BioCardia to report Q2 2026 financial results a... - Pluang
BioCardia (BCDA) Q1 2026 Earnings: Wider EPS Loss of $0.21 Misses Estimates, Yet Stock Climbs 5.04%Earnings Outlook Update - dars.gov.et
BioCardia Inc. (BCDA) Q1 2026 Earnings: EPS Miss Magnifies Loss Amid Pre-Revenue StageCEO Earnings Statement - dars.gov.et
BioCardia CEO Peter Altman buys $3,900 in common stock By Investing.com - Investing.com Nigeria
Form 4 Biocardia Inc For: 29 July By Investing.com - Investing.com Nigeria
BioCardia CEO Peter Altman buys $3,900 in common stock - Investing.com
BioCardia Inc (BCDA) Valuation: PE, PB & Fair Value Analysis - TradingKey
What date does BioCardia's (BCDA) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
BioCardia Inc (BCDA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BCDA|BioCardia Inc|Price:0.824|Chg%:+0.053 - TradingKey
BioCardia Inc (BCDA) Cash Flow - TradingKey
TradingKey - TradingKey
BioCardia Inc (BCDA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BioCardia Inc (BCDA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BioCardia Inc (BCDA) Institutional Confidence - TradingKey
BioCardia Inc (BCDA) Balance Sheet - TradingKey
BCDA|BioCardia Inc|Price:0.850|Chg%:-0.055 - TradingKey
BioCardia, Inc. Revenue Breakdown – FWB:6JU0 - TradingView
BioCardia Inc. (BCDA) Q1 2026 Earnings: EPS Misses Estimates with No Reported RevenueEPS Consistency Score - dars.gov.et
BioCardia (BCDA) CEO Peter Altman purchases 500 shares in July 17 trade - Stock Titan
BioCardia (BCDA) Slips 3.4% as Stock Tests Key Support Near $0.79Zero Gamma Level - dars.gov.et
Form 4 Biocardia Inc For: 15 July By Investing.com - Investing.com Canada
BioCardia CEO Peter Altman buys $3,754 in company stock - Investing.com
Finanzdaten der Biocardia Inc-Aktie (BCDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):